| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q4 2018 | 3 | 38,077 | Apellis Pharmaceuticals, Inc, I9SA.HA, VYNE | 13F-HR | 2/14/2019 | 000101297519000159 |
| Q3 2018 | 3 | 57,170 | Apellis Pharmaceuticals, Inc, VYNE, I9SA.HA | 13F-HR | 11/14/2018 | 000173705318000003 |
| Q2 2018 | 4 | 96,922 | Apellis Pharmaceuticals, Inc, I9SA.HA, VYNE, NBRV | 13F-HR | 8/14/2018 | 000101297518001014 |
| Q1 2018 | 4 | 162,246 | Apellis Pharmaceuticals, Inc, VYNE, I9SA.HA, NBRV | 13F-HR | 4/25/2018 | 000173705318000002 |
| Q4 2017 | 3 | 100,757 | Apellis Pharmaceuticals, Inc, NBRV, I9SA.HA | 13F-HR | 4/25/2018 | 000173705318000001 |